Showing Results for
- Academic Journals (51)
Search Results
- 51
Academic Journals
- 51
-
From:PLoS ONE (Vol. 12, Issue 2) Peer-ReviewedTuberculosis (TB) is one of the most important cause of morbidity and death among infectious diseases, and continuous efforts are needed to improve diagnostic tools and therapy. Previous published studies showed that...
-
From:Journal for ImmunoTherapy of Cancer (Vol. 7, Issue 1) Peer-ReviewedHuman (gamma delta) [gamma][delta] T cells are unconventional innate-like lymphocytes displaying a broad array of anti-tumor activities with promising perspectives in cancer immunotherapy. In this context,...
-
From:Arthritis Research & Therapy (Vol. 20, Issue 1) Peer-ReviewedBackground We aimed to evaluate the phenotype, function, and microRNA (miRNA)17-92 cluster expression in V[gamma]9V[delta]2 T-cell subsets and the correlation with immune response in rheumatoid arthritis (RA)...
-
From:PLoS ONE (Vol. 4, Issue 5) Peer-ReviewedCD8 T-cells contribute to control of Mycobacterium tuberculosis infection, but little is known about the quality of the CD8 T-cell response in subjects with latent infection and in patients with active tuberculosis...
-
From:Proceedings of the National Academy of Sciences of the United States (Vol. 116, Issue 24) Peer-ReviewedAbstract Only
-
From:PLoS ONE (Vol. 11, Issue 2) Peer-ReviewedObjective The aim of this study was to evaluate over time circulating [gamma][delta] T lymphocytes in melanoma patients in terms of frequency, effector functions, and relationship with clinical stage and evolution,...
-
From:Stem Cell Research & Therapy (Vol. 8, Issue 1) Peer-ReviewedBackground The use of stem cells, including mesenchymal stem cells (MSCs), for regenerative medicine is gaining interest for the clinical benefits so far obtained in patients. This study investigates the use of...
-
From:Oncology (Vol. 93, Issue 6) Peer-ReviewedBackground/Aim: A clinical trial demonstrated that treatment with oral multikinase regorafenib improved overall survival (OS), progression-free survival (PFS), and disease control [García-Alfonso et al.: J Clin...
-
From:Immunotherapy (Vol. 6, Issue 9) Peer-ReviewedAuthor(s): Thiranut Ramutton aff1 , Simona Buccheri aff1 aff2 , Francesco Dieli [*] aff1 aff2 , Matilde Todaro aff2 aff3 , Giorgio Stassi aff3 , Serena Meraviglia aff1 Keywords: colon cancer; HDAC inhibitor;...
-
From:PLoS ONE (Vol. 10, Issue 9) Peer-ReviewedIntracellular cytokine staining combined with flow cytometry is one of a number of assays designed to assess T-cell immune responses. It has the specific advantage of enabling the simultaneous assessment of multiple...
-
From:Molecular Cancer (Vol. 14, Issue 1) Peer-ReviewedBackground CD90+ liver cancer cells have been described as cancer stem-cell-like (CSC), displaying aggressive and metastatic phenotype. Using two different in vitro models, already described as CD90+ liver cancer...
-
From:PLoS ONE (Vol. 14, Issue 12) Peer-ReviewedBackground Currently, there are serious limitations in the direct diagnosis of active tuberculosis (ATB). We evaluated the levels of the IL-18/IL-37/IP-10 signalling complex proteins in Mycobacterium tuberculosis...